Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases

Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases

Objective Evaluate spondyloarthritis (SpA) incidence in inflammatory bowel diseases (IBD) between patients treated with biological disease-modifying antirheumatic drugs (bDMARDs) and conventional DMARDs (cDMARDs) and define risk factors associated with SpA development.Methods Retrospective cohort st...

Full description

Bibliographic Details
Main Authors: Paola Conigliaro, Maria Sole Chimenti, Paola Triggianese, Alberto Bergamini, Mauro Fatica, Benedetta Monosi, Arianna D’Antonio, Sara Essofi, Elisa Cuccagna, Livia Biancone, Giovanni Monteleone, Emma Calabrese
Format: Article
Language:English
Published: BMJ Publishing Group 2024-02-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/10/1/e003820.full

Internet

https://rmdopen.bmj.com/content/10/1/e003820.full

Similar Items